bevacizumab,cetuximab
roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'cetuximab', 'fire-4']
#asco23 fire-4 study: influence of baseline liquid biopsy results in first-line treatment efficacy of folfiri/cetuximab in patients with tissue ras-wt mcrc liquid biopsy detected ras mutation in 13% of patients deemed raswt based on tissue analyses these patients had 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm